UK – DHSC publishes Brexit guidance for pharmaceutical industry and suppliers of medical devices

The Health and Social Care Secretary has written 2 letters to industry about contingency plans in the unlikely event of a no-deal Brexit.

In his letter to pharmaceutical companies (PDF65.9KB3 pagesMatt Hancock asks suppliers to:

  • increase their medicines stocks by at least 6 weeks on top of their usual buffer stocks
  • ensure plans are in place to air freight products with a short shelf life that cannot be stockpiled

In his letter to suppliers of medical devices and clinical consumables (PDF62.3KB2 pageshe says that:

  • separate contingency plans are being developed
  • stock holding at a national level will be increased
  • further information will be provided to industry in September

The Department of Health and Social Care has published additional guidance for the pharmaceutical industry.

Six technical notices relating to health have been published by the government, covering…